From: Technology platform development for targeted plasma metabolites in human heart failure
Metabolite name | Accesion # | Monophasic | Biphasic | ||||
---|---|---|---|---|---|---|---|
1:3 Methanol | 1:3 Ethanol | 1:9 Methanol | 1:9 Ethanol | Methanol/Chloroform | Ethanol/Chloroform | ||
Hexanoic acid | HMDB00535 | x | x | x | |||
Succinate | HMDB00254 | x | |||||
Hypoxanthine | HMDB00157 | x | x | ||||
L-lysine | HMDB00182 | x | |||||
Uric acid | HMDB00289 | x | |||||
L-Arginine | HMDB00517 | x | |||||
Dodecanoic acid | HMDB00638 | x | x | x | x | ||
Palmitatic acid | HMDB00220 | x | x | x | x | x | x |
Linoleatic acid | HMDB00673 | x | x | x | x | x | x |
Stearic acid | HMDB00827 | x | x | x | x | x | x |